CRISPR Therapeutics AG

CRSP

Add to Watchlist

54.090USD

+1.000+1.88%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

5.19BMarket Cap

LossP/E TTM

CRISPR Therapeutics AG

54.090

+1.000+1.88%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-06-18

Previous score

7.00

Change

The current institutional shareholding score of CRISPR Therapeutics AG is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.16%, representing a quarter-over-quarter decrease of 7.94%. The largest institutional shareholder is Catherine Wood, holding a total of 10.05M shares, representing 11.74% of shares outstanding, with 0.08% increase in holdings.